Generalized anxiety disorder: clinical presentation, diagnostic features, and guidelines for clinical practice

2010 ◽  
Vol 67 (1) ◽  
pp. 58-73 ◽  
Author(s):  
Colin van der Heiden ◽  
Gerda Methorst ◽  
Peter Muris ◽  
Henk T. van der Molen
Keyword(s):  
Clinical Practice ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Clinical Presentation ◽  
Generalized Anxiety ◽  
Diagnostic Features

Generalized anxiety disorder is under-recognized in clinical practice in patients with alcohol dependence in France

Alcohol ◽  
2013 ◽  
Vol 47 (1) ◽  
pp. 15-19 ◽  
Author(s):  
Violaine Charriau ◽  
M'hammed Elyakoubi ◽  
Bruno Millet ◽  
Dominique Drapier ◽  
Didier Robin ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Anxiety Disorder ◽  
Alcohol Dependence ◽  
Generalized Anxiety Disorder ◽  
Generalized Anxiety

Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder

2004 ◽  
Vol 20 (1) ◽  
pp. 3-13 ◽  
Author(s):  
Meir Steiner ◽  
Christer Allgulander ◽  
Arun Ravindran ◽  
Hana Kosar ◽  
Tal Burt ◽  
...  
Keyword(s):  
Gender Differences ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Clinical Presentation ◽  
Generalized Anxiety

scholarly journals Biological markers of generalized anxiety disorder

2017 ◽  
Vol 19 (2) ◽  
pp. 147-158 ◽  
Keyword(s):  
Mental Health ◽  
Clinical Practice ◽  
Anxiety Disorder ◽  
Mental Disorders ◽  
Generalized Anxiety Disorder ◽  
Biological Markers ◽  
Health Condition ◽  
Generalized Anxiety ◽  
Mental Health Condition ◽  
Potential Biomarkers

Generalized anxiety disorder (GAD) is a prevalent and highly disabling mental health condition; however, there is still much to learn with regard to pertinent biomarkers, as well as diagnosis, made more difficult by the marked and common overlap of GAD with affective and anxiety disorders. Recently, intensive research efforts have focused on GAD, applying neuroimaging, genetic, and blood-based approaches toward discovery of pathogenetic and treatment-related biomarkers. In this paper, we review the large amount of available data, and we focus in particular on evidence from neuroimaging, genetic, and neurochemical measurements in GAD in order to better understand potential biomarkers involved in its etiology and treatment. Overall, the majority of these studies have produced results that are solitary findings, sometimes inconsistent and not clearly replicable. For these reasons, they have not yet been translated into clinical practice. Therefore, further research efforts are needed to distinguish GAD from other mental disorders and to provide new biological insights into its pathogenesis and treatment.

Sign in / Sign up

Export Citation Format

Share Document